Crescent Capital BDC (CCAP) Scheduled to Post Quarterly Earnings on Wednesday

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of $0.59 per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last announced its quarterly earnings results on Wednesday, February 21st. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.57 by $0.04. Crescent Capital BDC had a net margin of 45.54% and a return on equity of 11.32%. The company had revenue of $50.00 million for the quarter, compared to analysts’ expectations of $47.99 million. On average, analysts expect Crescent Capital BDC to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Crescent Capital BDC Stock Up 0.5 %

CCAP stock opened at $17.58 on Tuesday. Crescent Capital BDC has a fifty-two week low of $13.30 and a fifty-two week high of $18.00. The company has a market capitalization of $651.51 million, a price-to-earnings ratio of 7.68 and a beta of 0.81. The business’s 50 day moving average price is $17.15 and its two-hundred day moving average price is $16.83. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.98 and a current ratio of 0.98.

Crescent Capital BDC Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Friday, March 29th were paid a $0.41 dividend. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $1.64 annualized dividend and a yield of 9.33%. Crescent Capital BDC’s payout ratio is 71.62%.

Analyst Ratings Changes

A number of research firms have recently weighed in on CCAP. Oppenheimer upped their target price on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “outperform” rating in a research report on Friday, February 23rd. Wells Fargo & Company boosted their price target on Crescent Capital BDC from $16.00 to $16.50 and gave the stock an “equal weight” rating in a research report on Monday, January 29th.

Check Out Our Latest Analysis on CCAP

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Articles

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.